Abstract:Cobalamin-dependent methionine synthase, with a cofactor of vitamin B12, catalyzes the reaction of 5-methyltetrahydrofolate and homocysteine to form methionine and tetrahydrofolate, which takes a core position in folate cycle, one-carbon-unit transfer, and sulfur amino acid pathways. The 'methyl folate trap' hypothesis suggests that methionine synthase is a potential target for anticancer drug development. ZL031 and ZL033 are 5-methyltetrahydrofolate-like compounds that have been newly synthesized as potential inhibitors of the enzyme. To identify the effect of these two compounds on methionine synthase activity, a spectrophotometric assay was used and the results proved that ZL031 and ZL033 inactivated methionine synthase in HL-60 cells with an IC50 dose of 10.0 and 1.4 mu mol/l, respectively. Moreover, obvious inhibitory effect on proliferation of HL-60 cells was observed, leading to our further investigation of the underlying anticancer mechanism. Under the circumstances of methionine synthase deficiency and subsequent folate depletion, cell cycle was arrested in G1/S phase and apoptosis was also observed. Analysis of cell cycle regulatory proteins demonstrated that cyclin E and cyclin-dependent kinase 2 were both increased. Furthermore, reduction of caspase-3, poly (ADP-ribose) polymerase, caspase-8, and caspase-9 protein levels were observed. In all the biological experiments we have performed, ZL033 has shown a better efficacy compared with ZL031. These results suggest that ZL031 and ZL033, as novel methionine synthase inhibitors, caused G1/S phase delay and apoptosis and eventually inhibit the proliferation of HL-60 cells in vitro. ZL033, with a carboxylic acid substituent, might have a better potential for drug development than ZL031 with an ester substituent.

Progress in the studies on methionine synthase inhibitors

Study on Inhibitors of Methionine Synthase VIII: Synthesis of 2,5-Diamino-4-oxo-6- (3-Butenyl) Pyrimidine

Design, Synthesis and Biological Activity of N5-substituted Tetrahydropteroate Analogs As Non-Classical Antifolates Against Cobalamin-Dependent Methionine Synthase and Potential Anticancer Agents

Mechanism-Based Design, Synthesis and Biological Studies of N-5-Substituted Tetrahydrofolate Analogs As Inhibitors of Cobalamin-Dependent Methionine Synthase and Potential Anticancer Agents

Research progress of methionine dependence inhibition of tumor growth

A review on L-methioninase in cancer therapy: Precision targeting, advancements and diverse applications for a promising future

Two newly synthesized 5-methyltetrahydrofolate-like compounds inhibit methionine synthase activity accompanied by cell cycle arrest in G1/S phase and apoptosis in vitro.

A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight

Methionine metabolism in chronic liver diseases: an update on molecular mechanism and therapeutic implication

Targeting methionine metabolism in cancer: opportunities and challenges

The methionine cycle and its cancer implications

Recent progress in DNA methyltransferase inhibitors as anticancer agents

Antifolate agents: a patent review (2006 - 2010)

Progress in the discovery and development of small molecule methuosis inducers

DNA Methyltransferases: Emerging Targets for the Discovery of Inhibitors As Potent Anticancer Drugs

Therapeutic targeting of the mitochondrial one-carbon pathway: perspectives, pitfalls, and potential

Discovery of cysteine-targeting covalent histone methyltransferase inhibitors

Targeting protein methylation: from chemical tools to precision medicines

Biomedical Applications of Methionine-Based Systems

The Recent Development of Farnesyltransferase Inhibitors As Anticancer and Antimalarial Agents.

Unlocking the potential of methionine: a dietary supplement for preventing colitis